Previous 10 | Next 10 |
Summary Twist operates in a trendy space, with good growth, but atrocious margins. As profits are not in the company’s DNA, losses are likely to continue. Although the stock is down a lot, it still trades at a healthy valuation. The stock has limited downside protection i...
Credit Suisse has downgraded Danaher ( NYSE: DHR ) to neutral from outperform due to its exposure to bioprocessing inventory reductions and diagnostics potentially pressuring growth. The firm also cut its price target to $300 from $315 (~13% upside based on Wednesday's close). Ana...
Summary In today's article, we provide a fourth-quarter update on our Inverse Jim Cramer strategy analyzing the performance, or lack thereof, behind his top-mentioned stock recommendations. This was yet another quarter in which we showed that inverting Jim Cramer's highest conviction pi...
Summary General Electric successfully spun off GE HealthCare Technologies, resulting in one publicly-traded company turning into two. Though the transformation for General Electric is not complete, this does set up investors for tremendous upside potential. GE HealthCare Industries ...
Summary My portfolio generated dividend growth of 11.4% in 2022. I added four new positions in December 2022 and added to several existing positions. My portfolio saw 6 dividend raises and no dividend cuts in December 2022. I am anticipating 4 dividend raises in January 2023. ...
Danaher to Present at J.P. Morgan Healthcare Conference PR Newswire WASHINGTON , Jan. 3, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair , will be presenting at the J.P. Morgan Healthc...
Given the decline in the market in 2022 and the fall in share prices of all three stocks discussed here, it might seem odd to single them out as being "too expensive." Add the fact that Rockwell Automation (NYSE: ROK) , multi-industry industrial Illinois Tool Works (NYSE: ITW) , a...
Summary I look at my updated top 10 holdings and note which companies I want to add to and which ones I intend to leave steady. I highlight some "Compounder" names I'm looking to add in 2023. I touch on the four new positions I added to my portfolio this month. I discuss four co...
Danaher Schedules Fourth Quarter 2022 Earnings Conference Call PR Newswire WASHINGTON , Dec. 27, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2022 on Tuesday, J...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend C...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...